Gateway to Biotech: Top researchers met industry experts in the Faculty Club at IZB
- 16. Mai 2019
- 1 Min. Lesezeit
May 16, 2019
Michael Almstetter, CEO Origenis GmbH, explained what can be learned from progress in oncology in order to develop new treatments for Alzheimer’s and Parkinson’s disease.
